Subscribe to eTOC

UPCOMING COVERAGE OF ANNUAL MEETING 2004

Neurology Today will be providing extensive coverage of plenary sessions and new research from the 2004 Annual Meeting. In upcoming issues, expect coverage of these plenaries:

  • Presidential Lecture by Eric R. Kandel, MD, Founding Director of the Center for Neurobiology and Behavior and Howard Hughes Medical Institute investigator at Columbia University in New York, NY. Dr. Kandel is the Nobel laureate for his research into signal transduction in the nervous system and his discoveries on how the efficiency of synapses can be modified, and which molecular mechanisms take part.
  • Figure

    Dr. Huda Zoghbi is the Robert Wartenberg Lecturer.

  • Robert Wartenberg Lecture by Huda Zoghbi, MD, Professor of Pediatrics, Neurology, Neuroscience, and Molecular and Human Genetics at Baylor College of Medicine in Houston, TX, on “Rett Syndrome and MeCP2 Chromatin Remodeling and Neurobehavioral Disorders.”
  • Figure

    Dr. William C. Mobley is presenting the George C Cotzias Lecture.

  • George C. Cotzias Lecture by William C. Mobley, MD, PhD, Chair of the Department of Neurology and Neurological Sciences at Stanford University, on “Trafficking the Target-Derived Signals of Neurotrophic Factors: Implications for Normal and Degenerating Neurons.”
  • Frontiers in Clinical Neurosciences Plenaries with Kevin P. Campbell, PhD, Professor of Physiology and Biophysics an Neurology at University of Iowa College of Medicine in Iowa City, on “Dystroglycan and Congenital Muscular Dystrophy with Stuctural and Functional Brain Abnormalities;”
  • Figure

    Dr. Kevin P. Campbell is presenting on the role of dystroglan in molecular studies of muscular dystrophy.

  • Robert Darnell, MD, PhD, Professor and Laboratory Head of Molecular Neuro-oncology at Rockefeller University in New York, NY, on “RNA Binding Proteins and Neurologic Disease;”
  • Richard M. Ransohoff, MD, Associate Professor in the Department of Neurology and Meurosciences at Cleveland Clinic Foundation, on “What Does Chemokine Biology Teach Us About Diseases of the Nervous System?”
  • Lennart Mucke, MD, Director and Senior Investigator of the Gladstone Institute of Neurological Disease and Professor of Neurology and Neuroscience at University of California-San Francisco.

In addition, look for coverage of these and other stories:

  • soldiers at higher risk for ALS
  • the search for biomarkers in neurodegenerative diseases
  • brain plasticity after stroke
  • serotonergic therapies for aphasia
  • chemotherapies for brain tumors
  • racial and ethnic disparities in neurologic care
  • the neuropathology of mild cognitive impairment
  • genetic susceptibility factors for Parkinson disease
  • comparison of endovascular and neurosurgical treatments for stroke
  • optimizing interferon dosage for MS
  • hypothalamic stimulation for cluster headaches
  • Figure

    Dr. Richard M. Ransohoff will discuss the role of chemochine biology in diseases of the nervous system.

  • advances in stem cell research
  • diagnosis of frontotemporal dementias
  • West Nile virus in organ transplant recipients
  • hypothalamus metabolism in narcolepsy
  • the impact of neurointensivists in critical care
  • education in ethics and patient safety
  • Figure

    Dr. Lennart Mucke will discuss markers and mediators of neuronal deficits in dementia.